Evidence map›Paper›PMID 22089171›Full record

ArticleCornea2011

Comparison of mucin levels at the ocular surface of postmenopausal women with and without a history of dry eye.

Ilene K Gipson, Sandra J Spurr-Michaud, Michelle Senchyna, Robert Ritter, Debra Schaumberg

Abstract read
In one paragraph

Article in Cornea, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Ocular surface glycocalyx in health and disease.Frontiers in cell and developmental biology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Transmembrane Mucin 1 Blocks Fluorescein Ingress to Corneal Epithelium.Investigative ophthalmology & visual science · 2022
    Article
  8. Human ocular mucins: The endowed guardians of sight.Advanced drug delivery reviews · 2022
    Review
  9. Article
  10. Short tear film breakup time-type of dry eye in India.Indian journal of ophthalmology · 2021
    Article
  11. Gene expression profiles of pro-inflammatory mediators in the conjunctiva of patients with epiblepharon.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Observational
  18. TFOS DEWS II Tear Film Report.The ocular surface · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ilene K GipsonSchepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA. Ilene.gipson@schepens.harvard.edu
Sandra J Spurr-Michaud
Michelle Senchyna
Robert Ritter
Debra Schaumberg
Alcon (China) · CNHarvard University Press · USHarvard University · US

Funding

MUCINS OF THE OCULAR SURFACER01EY003306 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI GIPSON, ILENE K. · 1985 to 2015
$8.9M
NEI NIH HHS R01 EY003306NEI NIH HHS R01 EY03306
6 · The paper itself

Abstract

purposeTo determine if levels of the glycocalyx membrane mucins, MUC1 and MUC16, and the secreted goblet cell mucin MUC5AC are altered in conjunctival cells and tears of postmenopausal women presenting with a history of non-Sjögren dry eye and if mucin levels correlate with dry eye clinical diagnostic data.

methodsEighty-four postmenopausal women with a history of non-Sjögren dry eye and 30 normal subjects were recruited for this study. Impression cytology samples were collected for mucin messenger RNA (mRNA) and protein analysis. Tears were collected for mucin protein assay. Quantitative polymerase chain reaction, Western blot, and enzyme-linked immunosorbent assay were used to quantitate MUC1, MUC16, and MUC5AC levels.

resultsPostmenopausal women with a history of dry eye displayed significantly increased MUC1 mRNA expression and cellular protein compared with normal subjects (P < 0.001 and P < 0.01, respectively). Similarly, cellular MUC16 protein levels were significantly higher (P < 0.001). Mucin levels were found to be correlated with the clinical characterization of the subjects, including staining and symptoms. Although cellular MUC5AC protein levels were increased in symptomatic subjects, the increase did not reach statistical significance.

conclusionsElevation in MUC1 and MUC16 mRNA and/or protein levels in postmenopausal women with non-Sjögren dry eye with a history of dry eye may be a compensatory response to irritation and inflammation associated with the disease. Understanding the pattern of mucin expression associated with the dry eye pathology may clarify factors involved in the progression of the disease and enhance the development of targeted therapies.

Indexed as

AgedAged, 80 and overBlotting, WesternCA-125 AntigenConjunctivaDry Eye SyndromesEnzyme-Linked Immunosorbent AssayEpithelial CellsFemaleHumansMembrane ProteinsMiddle AgedMucin-1Mucin 5ACPolymerase Chain ReactionPostmenopauseCA-125 AntigenMembrane ProteinsMUC16 protein, humanMucin-1Mucin 5ACRNA, Messenger

Identifiers

PMID22089171
PMCPMC3219908
OpenAlexW1965524311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.